Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biopredic International is a French privately owned biotechnology company that develops, manufactures, and distributes human and animal primary cells, tissues, subcellular fractions, and assay systems (notably HepaRG and Silensomes) for in vitro ADME, toxicology, hepatology, and dermo‑cosmetic research; it does not run its own therapeutic clinical programs.[2][4][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biopredic International.